MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics.
Gil-Redondo R, Conde R, Bruzzone C, Seco ML, Bizkarguenaga M, González-Valle B, de Diego A, Laín A, Habisch H, Haudum C, Verheyen N, Obermayer-Pietsch B, Margarita S, Pelusi S, Verde I, Oliveira N, Sousa A, Zabala-Letona A, Santos-Martin A, Loizaga-Iriarte A, Unda-Urzaiz M, Kazenwadel J, Berezhnoy G, Geisler T, Gawaz M, Cannet C, Schäfer H, Diercks T, Trautwein C, Carracedo A, Madl T, Valenti L, Spraul M, Lu SC, Embade N, Mato JM, Millet O.
Gil-Redondo R, et al. Among authors: conde r.
Cardiovasc Diabetol. 2024 Jul 24;23(1):272. doi: 10.1186/s12933-024-02363-3.
Cardiovasc Diabetol. 2024.
PMID: 39048982
Free PMC article.